Julie Krop - 11 Aug 2025 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role: Chief Marketing Officer
Signature: /s/ Joshua L. Colburn, attorney-in-fact
Issuer symbol: DMAC
Transactions as of: 11 Aug 2025
Net transactions value: $0
Form type: 4
Filing time: 03 Nov 2025, 16:32:02 UTC
Previous filing: 12 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Krop Julie	Chief Marketing Officer	301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS	/s/ Joshua L. Colburn, attorney-in-fact	03 Nov 2025	0001643127

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DMAC	Stock Option (right to buy)	Award	$0	+450,000		$0.000000	450,000	11 Aug 2025	Common Stock	450,000	$4.58	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	112,500 shares vest on the one-year anniversary of the grant date, and the remaining 337,500 shares vest in twelve equal, or as nearly equal as possible, quarterly installments commencing three months after the one-year anniversary of the grant date; provided, however, that the participant remains continuously employed by or provides services to the Company, or one of its Subsidiaries or Affiliates, through the applicable vesting date.

Content

112,500 shares vest on the one-year anniversary of the grant date, and the remaining 337,500 shares vest in twelve equal, or as nearly equal as possible, quarterly installments commencing three months after the one-year anniversary of the grant date; provided, however, that the participant remains continuously employed by or provides services to the Company, or one of its Subsidiaries or Affiliates, through the applicable vesting date.